Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Payables (2022 - 2025)

Prokidney (PROK) has disclosed Payables for 4 consecutive years, with $1.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Payables fell 31.86% to $1.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.9 million, a 31.86% decrease, with the full-year FY2024 number at $3.6 million, down 28.74% from a year prior.
  • Payables was $1.9 million for Q3 2025 at Prokidney, down from $2.4 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $5.1 million in Q4 2023 to a low of $26735.0 in Q1 2022.
  • A 4-year average of $3.1 million and a median of $3.1 million in 2022 define the central range for Payables.
  • Peak YoY movement for Payables: skyrocketed 14117.32% in 2023, then crashed 36.33% in 2024.
  • Prokidney's Payables stood at $3.0 million in 2022, then soared by 67.48% to $5.1 million in 2023, then decreased by 28.74% to $3.6 million in 2024, then tumbled by 46.55% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for PROK's Payables are $1.9 million (Q3 2025), $2.4 million (Q2 2025), and $3.1 million (Q1 2025).